Monoblastien

Monoblastien, also known as monoblasts, are immature precursor cells belonging to the myeloid lineage of hematopoietic tissue. They arise from common myeloid progenitors in the bone marrow and represent the earliest recognizable stage in the development of monocytes, macrophages, and dendritic cells. Morphologically, monoblastien are large cells with a high nuclear‑to‑cytoplasmic ratio, a round to oval nucleus, fine chromatin, and often one to three prominent nucleoli. The cytoplasm is basophilic, may contain azurophilic granules, and lacks the abundant vacuolation observed in more mature monocytes.

During normal hematopoiesis, monoblastien differentiate into promonocytes, which further mature into monocytes that enter the peripheral blood. In tissues, monocytes can differentiate again into macrophages or dendritic cells, participating in innate immunity, phagocytosis, and antigen presentation. The presence and proportion of monoblastien are routinely assessed in bone‑marrow examinations, especially when evaluating leukemias. An increased number of monoblastien is a diagnostic feature of acute monoblastic/monocytic leukemia (AML M5 according to the French‑American‑British classification), where malignant transformation arrests development at the monoblast stage.

Clinically, identification of monoblastien relies on cytomorphology and immunophenotyping; the cells typically express myeloid markers such as CD13, CD33, and the monocytic marker CD14, while lacking lymphoid antigens. Research into the regulation of monoblast differentiation has highlighted transcription factors like PU.1 and C/EBPα, as well as cytokines such as macrophage colony‑stimulating factor (M‑CSF), which together coordinate lineage commitment and maturation.